Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Infographic – 72,000 Opioid Overdose Deaths in 2017

Drug overdose deaths

A preliminary report from the Centers for Disease Control and Prevention shows that more than 72,000 deaths from opioid overdose were reported for 2017. . . . → Read More: Infographic – 72,000 Opioid Overdose Deaths in 2017

Nanoparticle Process Designed to Detect, Treat Oral Bacteria

Streptococcus mutans

A bioengineering lab devised a way to quickly detect and treat bacteria responsible for tooth decay with a combination of X-rays and a non-toxic compound in nanoscale particles. . . . → Read More: Nanoparticle Process Designed to Detect, Treat Oral Bacteria

Pfizer, Biotech Partner on RNA Flu Vaccine

3-D print of influenza virus

A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins. . . . → Read More: Pfizer, Biotech Partner on RNA Flu Vaccine

Peptide Pain Drugs in Development Aimed at Alternative Targets

Neuron

Pain drugs made from peptides, small protein-like compounds, and guided by antibodies are being developed as alternatives to prescription opioids to treat moderate to severe pain. . . . → Read More: Peptide Pain Drugs in Development Aimed at Alternative Targets

Low-Dose Triple Pill Reduces Blood Pressure in More People

3 generic capsules

A clinical trial shows a single medication with low doses of three common drugs reduces high blood pressure in more people with the condition than the normal care. . . . → Read More: Low-Dose Triple Pill Reduces Blood Pressure in More People

Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million

Magnolia Neuroscience

A new company is forming to develop treatments that protect against destruction of brain cells in Alzheimer’s disease and comparable nerve damage from chemotherapy. . . . → Read More: Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million

FDA Approves RNA-Interference Nerve Disease Therapy

Onpattro

A treatment that silences the actions of RNA and reverses damage to nerves from a rare inherited neurological disease was approved by the Food and Drug Administration. . . . → Read More: FDA Approves RNA-Interference Nerve Disease Therapy

Cancer Drug Delivery Through Milk Particles Under Study

Cattle

A new research project is investigating components in raw cow’s milk that could make it possible to give chemotherapy for cancer as oral drugs rather than infusions. . . . → Read More: Cancer Drug Delivery Through Milk Particles Under Study

Start-Up Developing Regenerative Liver Disease Treatments

Damaged liver cells

A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions. . . . → Read More: Start-Up Developing Regenerative Liver Disease Treatments

Allergan Licensing Crispr for Inherited Eye Disease

Editing DNA

Drug maker Allergan is acquiring the rights from Editas Medicine to develop an application of the genome-editing technology Crispr for the inherited eye disease Leber congenital amaurosis type 10. . . . → Read More: Allergan Licensing Crispr for Inherited Eye Disease